21 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
14 May 24
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
7:45am
limitation, general market conditions; Xilio’s ability to successfully achieve the benefits of the strategic portfolio reprioritization and workforce
8-K
EX-99.1
zofa060p4v93h76sme
1 Apr 24
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
4:15pm
8-K
khdc0lqxm
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-99.2
5ofnb174s4ggd fz7j2
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
10-K
vttd24y
1 Mar 22
Annual report
4:07pm
10-Q
qgyl 3g17l
2 Dec 21
Quarterly report
4:15pm
424B4
ve0njf0 so
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
cc07 5zuf13
18 Oct 21
IPO registration (amended)
6:04am
S-1
xcju8 cxn31lks7
1 Oct 21
IPO registration
4:49pm
DRS/A
tm052 eaouu1rof4t8
14 Sep 21
Draft registration statement (amended)
12:00am